Search Results

There are 10087 results for: content related to: Hepatitis C viral infection in patients with chronic kidney disease

  1. You have free access to this content
    HCV Therapeutics: Approved Agents

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 1091A–1168A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26880

  2. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Version of Record online : 1 OCT 2012, DOI: 10.1002/hep.26040

  3. You have free access to this content
    British HIV Association guidelines for the management of hepatitis viruses in adults infected with HIV 2013

    HIV Medicine

    Volume 14, Issue S4, November 2013, Pages: 1–71, Writing Group, Dr Ed Wilkins, Dr Mark Nelson, Dr Kosh Agarwal, Ms Dola Awoyemi, Dr Eleanor Barnes, Dr Sanjay Bhagani, Dr Gary Brook, Dr Ashley Brown, Ms Sheena Castelino, Dr Graham Cooke, Prof Martin Fisher, Prof Anna Maria Geretti, Mr Robert James, Dr Ranjababu Kulasegaram, Prof Clifford Leen, Prof David Mutimer, Dr Chloe Orkin, Dr Emma Page, Dr Adrian Palfreeman, Dr Padmasayee Papineni, Dr Alison Rodger and Dr CY William Tong

    Version of Record online : 25 OCT 2013, DOI: 10.1111/hiv.12106

  4. You have free access to this content
    Triple therapy for HCV genotype 1 infection: telaprevir or boceprevir?

    Liver International

    Volume 32, Issue s1, February 2012, Pages: 54–60, Mitchell L. Shiffman and Rafael Esteban

    Version of Record online : 29 DEC 2011, DOI: 10.1111/j.1478-3231.2011.02718.x

  5. You have full text access to this OnlineOpen article
    A Model-Based Illustrative Exploratory Approach to Optimize the Dosing of Peg-IFN/RBV in Cirrhotic Hepatitis C Patients Treated With Triple Therapy

    CPT: Pharmacometrics & Systems Pharmacology

    Volume 4, Issue 1, January 2015, Pages: 37–40, C Laouénan, J Guedj, G Peytavin, TH Tram Nguyen, M Lapalus, F Khelifa-Mouri, N Boyer, F Zoulim, L Serfaty, J-P Bronowicki, M Martinot-Peignoux, O Lada, T Asselah, C Dorival, C Hézode, F Carrat, F Nicot, P Marcellin, F Mentré and for the ANRS CO20-CUPIC Study Group

    Version of Record online : 30 DEC 2014, DOI: 10.1002/psp4.8

  6. You have free access to this content
    Direct acting antivirals for the treatment of chronic hepatitis C: one pill a day for tomorrow

    Liver International

    Volume 32, Issue s1, February 2012, Pages: 88–102, Tarik Asselah and Patrick Marcellin

    Version of Record online : 29 DEC 2011, DOI: 10.1111/j.1478-3231.2011.02699.x

  7. New Pharmacotherapy for Hepatitis C

    Clinical Pharmacology & Therapeutics

    Volume 92, Issue 3, September 2012, Pages: 294–305, D N Assis and J K Lim

    Version of Record online : 1 AUG 2012, DOI: 10.1038/clpt.2012.103

  8. You have free access to this content
    JSH Guidelines for the Management of Hepatitis B Virus Infection

    Hepatology Research

    Volume 44, Issue S1, January 2014, Pages: 1–58, Drafting Committee for Hepatitis Management Guidelines and the Japan Society of Hepatology

    Version of Record online : 7 JAN 2014, DOI: 10.1111/hepr.12269

  9. You have free access to this content
    Phase III results of Boceprevir in treatment naïve patients with chronic hepatitis C genotype 1

    Liver International

    Volume 32, Issue s1, February 2012, Pages: 27–31, Michael P. Manns, Antoaneta A. Markova, Beatriz Calle Serrano and Markus Cornberg

    Version of Record online : 29 DEC 2011, DOI: 10.1111/j.1478-3231.2011.02725.x

  10. Hepatitis C

    Standard Article

    Wiley Handbook of Current and Emerging Drug Therapies

    Published Online : 15 SEP 2006, DOI: 10.1002/9780470041000.cedt033

  11. You have free access to this content
    Poster Session 2: Hepatitis C: Approved Therapeutic Agents

    Hepatology

    Volume 60, Issue S1, October 2014, Pages: 659A–709A,

    Version of Record online : 1 OCT 2014, DOI: 10.1002/hep.27516

  12. You have free access to this content
    New HCV therapies on the horizon

    Clinical Microbiology and Infection

    Volume 17, Issue 2, February 2011, Pages: 122–134, J. Vermehren and C. Sarrazin

    Version of Record online : 20 JAN 2011, DOI: 10.1111/j.1469-0691.2010.03430.x

  13. You have free access to this content
    Hepatitis C genotype 1 infection in HIV–Infected patients in the era of direct-acting antiviral therapy

    Clinical Liver Disease

    Volume 1, Issue 3, July 2012, Pages: 69–72, Mark S. Sulkowski

    Version of Record online : 23 JUL 2012, DOI: 10.1002/cld.51

  14. You have free access to this content
    Current and emerging antiviral treatments for hepatitis C infection

    British Journal of Clinical Pharmacology

    Volume 75, Issue 4, April 2013, Pages: 931–943, Joseph S. Doyle, Esther Aspinall, Danny Liew, Alexander J. Thompson and Margaret E. Hellard

    Version of Record online : 15 MAR 2013, DOI: 10.1111/j.1365-2125.2012.04419.x

  15. You have free access to this content
    How to optimize HCV therapy in genotype 1 patients with cirrhosis

    Liver International

    Volume 33, Issue s1, February 2013, Pages: 46–55, Marc Bourlière, Astrid Wendt, Hélène Fontaine, Christophe Hézode, Stanislas Pol and Jean Pierre Bronowicki

    Version of Record online : 3 JAN 2013, DOI: 10.1111/liv.12067

  16. Current prospects for interferon-free treatment of hepatitis C in 2012

    Journal of Gastroenterology and Hepatology

    Volume 28, Issue 1, January 2013, Pages: 38–45, Catherine AM Stedman

    Version of Record online : 19 DEC 2012, DOI: 10.1111/jgh.12028

  17. You have free access to this content
    Pharmacokinetic interaction between the hepatitis C virus protease inhibitor boceprevir and cyclosporine and tacrolimus in healthy volunteers

    Hepatology

    Volume 56, Issue 5, November 2012, Pages: 1622–1630, Ellen Hulskotte, Samir Gupta, Fengjuan Xuan, Marga van Zutven, Edward O'Mara, Hwa-Ping Feng, John Wagner and Joan Butterton

    Version of Record online : 14 OCT 2012, DOI: 10.1002/hep.25831

  18. You have free access to this content
    The protease inhibitor, GS-9256, and non-nucleoside polymerase inhibitor tegobuvir alone, with ribavirin, or pegylated interferon plus ribavirin in hepatitis C

    Hepatology

    Volume 55, Issue 3, March 2012, Pages: 749–758, Stefan Zeuzem, Peter Buggisch, Kosh Agarwal, Patrick Marcellin, Daniel Sereni, Hartwig Klinker, Christophe Moreno, Jean-Pierre Zarski, Yves Horsmans, Hongmei Mo, Sarah Arterburn, Steven Knox, David Oldach, John G. McHutchison, Michael P. Manns and Graham R. Foster

    Version of Record online : 23 FEB 2012, DOI: 10.1002/hep.24744

  19. You have free access to this content
    Vaniprevir with pegylated interferon alpha-2a and ribavirin in treatment-naïve patients with chronic hepatitis C: A randomized phase II study

    Hepatology

    Volume 56, Issue 3, September 2012, Pages: 884–893, Michael P. Manns, Edward Gane, Maribel Rodriguez-Torres, Albrecht Stoehr, Chau-Ting Yeh, Patrick Marcellin, Richard T. Wiedmann, Peggy M. Hwang, Luzelena Caro, Richard J.O. Barnard, Andrew W. Lee and for the MK-7009 Protocol 007 Study Group

    Version of Record online : 17 JUL 2012, DOI: 10.1002/hep.25743

  20. You have free access to this content
    Development and specificities of anti-interferon neutralizing antibodies in patients with chronic hepatitis C treated with pegylated interferon-α

    Clinical Microbiology and Infection

    Volume 18, Issue 10, October 2012, Pages: 1033–1039, C. Scagnolari, S. Trombetti, A. Soldà, M. Milella, G. B. Gaeta, G. Angarano, G. Scotto, N. Caporaso, F. Morisco, R. Cozzolongo, G. Giannelli, M. Fasano, T. Santantonio and G. Antonelli

    Version of Record online : 22 DEC 2011, DOI: 10.1111/j.1469-0691.2011.03729.x